Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7780]

Key one marrow protein identified as potential new leukaemia treatment target

Key one marrow protein identified as potential new leukaemia treatment target

AACR 2013: RNA interference drug demonstrated activity and safety in phase I trial

AACR 2013: RNA interference drug demonstrated activity and safety in phase I trial

AACR 2013: Engineered antibody demonstrated safety, efficacy in wide range of advanced tumours

AACR 2013: Engineered antibody demonstrated safety, efficacy in wide range of advanced tumours

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Novel drug combination showed antitumour activity in patients with incurable BRCA-deficient cancers

AACR 2013: Novel drug combination showed antitumour activity in patients with incurable BRCA-deficient cancers

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

AACR 2013: Potential targeted therapy from genomic analysis of head and neck cancer

AACR 2013: Potential targeted therapy from genomic analysis of head and neck cancer

Arrhythmia drug may increase cancer risk

Arrhythmia drug may increase cancer risk

More from ecancer